| Size & multiples | |||
| Market Cap | $200.2M | Enterprise Value | $217.7M |
| P/E (TTM) | 32.00× | PEG (trailing) | — |
| P/S | 1.41× | P/FCF | 8.70× |
| EV/EBITDA | 8.34× | EV/EBIT | 16.89× |
| EV/Sales | 1.53× | EV/FCF | 9.46× |
| FCF Yield | 11.49% | Buyback Yield | 3.89% |
| Owner Earnings (TTM) | $20.6M | Owner Earnings Yield | 10.27% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 1.41 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 11.05% |
| After-tax Cost of Debt | 3.87% | Synthetic credit rating | AA |
| Cost of Debt · embedded (pre-tax) | 6.20% | Cost of Debt · marginal (synthetic) | 4.55% |
| WACC | 10.41% | ROIC | 9.62% |
| EVA Spread (ROIC−WACC) | −0.79% | EVA | -$585,548 |
Synthetic rating = ICR-based credit-quality read (Damodaran), not an agency rating.
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted) · EPS TTM $0.31 · revenue TTM $142.4M · FCF TTM $23.0M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Cheap vs Health Care on EV/EBITDA; rich on P/E
P/E 66th · EV/EBITDA 23rd percentile in the Health Care pool — placement read per multiple; the API emits no single blended figure, so none is shown.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| P/E | 32.0x | 24.4x | 13.0x–39.3x | 66 ↑rich |
| EV/EBITDA | 8.6x | 15.1x | 9.8x–24.4x | 23 ↓cheap |
| FCF Yield | 11.9% | -7.8% | -34.7%–1.4% | 95 ↑strong |
| Net Margin | 4.6% | -21.2% | -325.3%–7.2% | 71 ↑strong |
| Operating Margin | 8.3% | -34.5% | -552.0%–8.0% | 75 ↑strong |
| ROE | 11.5% | -36.8% | -92.5%–4.5% | 82 ↑strong |
